Despite scoring a historic FDA approval last year, Adaptimmune Therapeutics is expressing concerns about its own longevity, ...

The American Medical Association and more than two dozen other health organizations joined in an amicus brief encouraging the ...

Raymond James Financial Inc. acquired a new position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund acquired 1,563,296 ...

The FDA has agreed to review an application from Roche that seeks approval in the U.S. of obinutuzumab as a treatment for ...

Shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) have earned a consensus rating of “Moderate Buy” from the eight ratings firms that are currently covering the stock, Marketbeat ...

But on the day of her surgery, fear turned into excitement as Dana made San Diego medical history. She became the first ...

February was heart months, and this is another column in a series about the major risk factors for heart attacks. According ...

To address the shortage of kidneys, a lobbying group aims to push a law in the US that financially compensates living donors.

Tegoprubart used as a key component of immunosuppression regimen in the second transplant of a genetically modified pig kidney into a human ...

Terumo India Private Limited, the Indian subsidiary of global medical technology leader Terumo Corporation (TSE: 4543), is marking DE&I week by expanding its commitment to workplace caregivers through ...

Tegoprubart used as a key component of immunosuppression regimen in the second transplant of a genetically modified pig kidney into a human conducted at Massachusetts General Hospital Announced positi ...

Fundraising efforts are underway to support the family of a local man unexpectedly diagnosed with Stage 4 cancer.